Genome-wide polygenic risk predictors for kidney disease
- PMID: 30279535
- PMCID: PMC8404375
- DOI: 10.1038/s41581-018-0067-6
Genome-wide polygenic risk predictors for kidney disease
Abstract
A new study reports that genome-wide polygenic risk scores can identify individuals at risk of common complex diseases, such as coronary artery disease or type 2 diabetes, with comparable performance to that of monogenic mutation screens. These findings support the potential clinical utility of genome-wide association study (GWAS)-based risk stratification; however, several issues need to be addressed before this approach can be applied to kidney disease.
Conflict of interest statement
Competing interests
The authors declare no competing interests.
Figures

Comment on
-
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.Nat Genet. 2018 Sep;50(9):1219-1224. doi: 10.1038/s41588-018-0183-z. Epub 2018 Aug 13. Nat Genet. 2018. PMID: 30104762 Free PMC article.
References
-
- Fox CS et al.Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study. J. Am. Soc. Nephrol 15, 2457–2461 (2004). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical